Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Pharmacological characterization of a potent inhibitor of autotaxin in animal models of inflammatory bowel disease and multiple sclerosis.
Evaluation of APR1 Gene Expression in Candida albicans Strains Isolated From Patients With Multiple Sclerosis.
US health insurance is an obstacle to disease-modifying treatments in MS.
Optimizing electrodiagnosis for Guillain-Barré syndrome: Clues from clinical practice.
Probiotics Lactobacillus plantarum and bifidobacterium B94: cognitive function in demyelinated model.
Myelin-related gene silencing mediated by LPA1 - Rho/ROCK signaling is correlated to acetylation of NFκB in S16 Schwann cells.
The contribution of depressive symptoms to slowness of information processing in relapsing remitting multiple sclerosis.
Fingolimod: A Disease-Modifier Drug in a Mouse Model of Amyotrophic Lateral Sclerosis.
Retinal Vascular Fractals Correlate With Early Neurodegeneration in Patients With Type 2 Diabetes Mellitus.
Differential effects of social isolation in adolescent and adult mice on behavior and cortical gene expression.
Role of FET proteins in neurodegenerative disorders.
Methylprednisolone microsphere sustained-release membrane inhibits scar formation at the site of peripheral nerve lesion.
Health Utilities for Multiple Sclerosis.
Preparation of purified perikaryal and synaptosomal mitochondrial fractions from relatively small hypothalamic brain samples.
The 11-year long-term follow-up study from the randomized BENEFIT CIS trial.
Shared and Distinct Patterns of Oligodendroglial Response in α-Synucleinopathies and Tauopathies.
Neuroanatomic Correlates of Female Sexual Dysfunction in Multiple Sclerosis.
Predictors of first-line treatment persistence in a Portuguese cohort of relapsing-remitting multiple sclerosis.
Combining HLA-DRB1-DQB1 and Mycobacterium Avium Subspecies Paratubercolosis (MAP) antibodies in Sardinian multiple sclerosis patients: associated or independent risk factors?
Peginterferon beta-1a versus other self-injectable disease-modifying therapies in the treatment of relapsing-remitting multiple sclerosis in Scotland: a cost-effectiveness analysis.
The Changing Landscape of Childhood Inflammatory Central Nervous System Disorders.
Evaluation of AD-MSC (adipose-derived mesenchymal stem cells) as a vehicle for IFN-β delivery in experimental autoimmune encephalomyelitis.
T cells in multiple sclerosis and experimental autoimmune encephalomyelitis.
Natalizumab Modifies Catecholamines Levels Present in Patients with Relapsing-Remitting Multiple Sclerosis.
Observational data: Understanding the real MS world.

Pages